EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pretreatment MRI Radiomics for Overall Survival Risk Stratification in Neuroendocrine Carcinoma of the Cervix: A Development and External Validation Study

Jian Chen, Fengle Jiang, Xingfa Chen, Rong Lin, Ning Ma, Haijuan Yu, Yang Sun

Tomography · 17.11.2026 · 12 (11) · 165

DOI: 10.3390/tomography12110165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tomography, online erschienen am 17.11.2026. Verfasst von Jian Chen und 6 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Fujian Provincial Health Technology Project.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neuroendocrine carcinoma of the cervix (NECC) is a rare malignancy, and pretreatment overall survival (OS) assessment remains limited. We developed and externally validated an MRI radiomics model for OS risk stratification.

Methods

This retrospective study included 128 patients: Center 1 served as the development cohort (n = 90), and Center 2 as the independent external validation cohort (n = 38). The model was selected using development data and locked before validation. Evaluation included Harrell C-index, inverse-probability-of-censoring-weighted (IPCW) AUC, calibration, Brier score, decision-curve analysis, and survival stratification.

Results

The model comprised three intratumoral T2-weighted imaging features fitted using CoxBoost 1.5.2. Its external C-index was 0.737 (95% CI, 0.615–0.850), compared with 0.633 (95% CI, 0.523–0.749) for the revised clinical model; the paired difference was 0.104 (95% CI, −0.018 to 0.226). A nested sensitivity analysis of the automated selection procedure yielded a mean C-index of 0.592 (SD, 0.049). IPCW AUCs were 0.741 (95% CI, 0.562–0.891) at 3 years and 0.763 (95% CI, 0.583–0.919) at 5 years. At 3 and 5 years, calibration intercepts were 0.03 and −0.09, slopes 1.14 and 1.20, and Brier scores 0.202 and 0.195, respectively. Exploratory decision-curve analysis suggested potential net benefit over selected thresholds. Hazard ratios (HRs; 95% CIs) for high versus low risk were 1.96 (1.06–3.62) and 3.61 (1.39–9.38) in the development and external cohorts, respectively. Corresponding HRs per development-cohort SD increase in the score were 1.83 (1.29–2.60) and 2.42 (1.45–4.04).

Conclusions

The pretreatment MRI radiomics model showed external prognostic discrimination for OS in NECC, but superiority over the pretreatment clinical model was not demonstrated. Further independent validation is needed.

Förderung

  • Natural Science Foundation of Fujian Province
  • Fujian Provincial Health Technology Project

Zitieren

APA

Chen, J., Jiang, F., Chen, X., Lin, R., Ma, N., Yu, H., & Sun, Y. (2026). Pretreatment MRI Radiomics for Overall Survival Risk Stratification in Neuroendocrine Carcinoma of the Cervix: A Development and External Validation Study. Tomography, 12(11), 165. https://doi.org/10.3390/tomography12110165

Vancouver

Chen J, Jiang F, Chen X, Lin R, Ma N, Yu H, et al. Pretreatment MRI Radiomics for Overall Survival Risk Stratification in Neuroendocrine Carcinoma of the Cervix: A Development and External Validation Study. Tomography. 2026;12(11):165. doi:10.3390/tomography12110165

BibTeX
@article{Chen2026,
  author = {Chen, Jian and Jiang, Fengle and Chen, Xingfa and Lin, Rong and Ma, Ning and Yu, Haijuan and Sun, Yang},
  title = {Pretreatment MRI Radiomics for Overall Survival Risk Stratification in Neuroendocrine Carcinoma of the Cervix: A Development and External Validation Study},
  journal = {Tomography},
  year = {2026},
  volume = {12},
  number = {11},
  pages = {165},
  doi = {10.3390/tomography12110165}
}
Kostenlos starten →